Solid Biosciences Inc. (SLDB)
NASDAQ: SLDB · Real-Time Price · USD
6.11
-0.57 (-8.53%)
Aug 14, 2025, 2:21 PM - Market open
Solid Biosciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 138.93 | 80.24 | 74.02 | 155.38 | 119.14 | 154.74 | Upgrade
|
| Short-Term Investments | 129.18 | 68.69 | 49.63 | 58.34 | 88.64 | - | Upgrade
|
| Cash & Short-Term Investments | 268.11 | 148.92 | 123.64 | 213.72 | 207.78 | 154.74 | Upgrade
|
| Cash Growth | 40.91% | 20.45% | -42.15% | 2.86% | 34.27% | 85.27% | Upgrade
|
| Receivables | - | - | - | - | 0.11 | - | Upgrade
|
| Prepaid Expenses | 3.3 | 1.65 | 2.11 | 3 | 8.71 | 1.48 | Upgrade
|
| Other Current Assets | 7.24 | 6.73 | 3.98 | 2.91 | 6.02 | 2.67 | Upgrade
|
| Total Current Assets | 278.64 | 157.3 | 129.73 | 219.64 | 222.61 | 158.9 | Upgrade
|
| Property, Plant & Equipment | 27.45 | 29.04 | 33.16 | 38.61 | 7.6 | 11.73 | Upgrade
|
| Other Long-Term Assets | 2.2 | 2.32 | 2.04 | 2.01 | 2.16 | 0.54 | Upgrade
|
| Total Assets | 308.29 | 188.66 | 164.94 | 260.25 | 232.38 | 171.17 | Upgrade
|
| Accounts Payable | 4.7 | 4.24 | 2.03 | 3.24 | 4.46 | 3.27 | Upgrade
|
| Accrued Expenses | 16.55 | 19.85 | 10.16 | 16.69 | 9.53 | 8.64 | Upgrade
|
| Current Portion of Leases | 2.9 | 3.02 | 2.32 | 2.57 | 1.5 | 2.21 | Upgrade
|
| Current Unearned Revenue | - | - | - | - | 8.08 | 10.36 | Upgrade
|
| Other Current Liabilities | 5.7 | 3.15 | - | 0.01 | 0.04 | - | Upgrade
|
| Total Current Liabilities | 29.85 | 30.26 | 14.52 | 22.51 | 23.6 | 24.48 | Upgrade
|
| Long-Term Leases | 20.16 | 21.16 | 23.94 | 25.98 | 0.57 | 2.94 | Upgrade
|
| Long-Term Unearned Revenue | - | - | - | - | - | 10.36 | Upgrade
|
| Other Long-Term Liabilities | - | - | - | 0.1 | - | 1.3 | Upgrade
|
| Total Liabilities | 50 | 51.42 | 38.46 | 48.59 | 24.17 | 39.08 | Upgrade
|
| Common Stock | 0.08 | 0.04 | 0.02 | 0.02 | 0.01 | 0.09 | Upgrade
|
| Additional Paid-In Capital | 1,120 | 920.61 | 785.2 | 774.45 | 685.01 | 536.57 | Upgrade
|
| Retained Earnings | -862.21 | -783.45 | -658.75 | -562.74 | -476.76 | -404.57 | Upgrade
|
| Comprehensive Income & Other | -0.04 | 0.05 | 0.02 | -0.07 | -0.05 | - | Upgrade
|
| Total Common Equity | 258.29 | 137.25 | 126.48 | 211.67 | 208.21 | 132.09 | Upgrade
|
| Shareholders' Equity | 258.29 | 137.25 | 126.48 | 211.67 | 208.21 | 132.09 | Upgrade
|
| Total Liabilities & Equity | 308.29 | 188.66 | 164.94 | 260.25 | 232.38 | 171.17 | Upgrade
|
| Total Debt | 23.05 | 24.18 | 26.27 | 28.55 | 2.06 | 5.15 | Upgrade
|
| Net Cash (Debt) | 245.06 | 124.74 | 97.38 | 185.18 | 205.72 | 149.59 | Upgrade
|
| Net Cash Growth | 48.55% | 28.11% | -47.41% | -9.98% | 37.52% | 95.66% | Upgrade
|
| Net Cash Per Share | 4.00 | 3.06 | 4.90 | 21.75 | 28.90 | 43.20 | Upgrade
|
| Filing Date Shares Outstanding | 77.87 | 77.49 | 37.76 | 19.57 | 7.36 | 5.68 | Upgrade
|
| Total Common Shares Outstanding | 77.6 | 40.47 | 20.39 | 19.56 | 7.36 | 5.66 | Upgrade
|
| Working Capital | 248.79 | 127.05 | 115.22 | 197.13 | 199.01 | 134.42 | Upgrade
|
| Book Value Per Share | 3.33 | 3.39 | 6.20 | 10.82 | 28.30 | 23.34 | Upgrade
|
| Tangible Book Value | 258.29 | 137.25 | 126.48 | 211.67 | 208.21 | 132.09 | Upgrade
|
| Tangible Book Value Per Share | 3.33 | 3.39 | 6.20 | 10.82 | 28.30 | 23.34 | Upgrade
|
| Machinery | - | 16.1 | 17.92 | 17.96 | 11.37 | 10.27 | Upgrade
|
| Construction In Progress | - | 0.88 | 0.41 | 1.72 | 1.49 | 1.33 | Upgrade
|
| Leasehold Improvements | - | 0.47 | 0.48 | 0.38 | 4.71 | 4.71 | Upgrade
|
Updated Aug 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.